PMC:1310901 / 27447-27680 JSONTXT

Annnotations TAB JSON ListView MergeView

    bionlp-st-ge-2016-reference-eval

    {"project":"bionlp-st-ge-2016-reference-eval","denotations":[{"id":"T14497","span":{"begin":28,"end":38},"obj":"Gene_expression"},{"id":"T14560","span":{"begin":22,"end":27},"obj":"Protein"}],"relations":[{"id":"R11975","pred":"themeOf","subj":"T14560","obj":"T14497"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    events-check-again

    {"project":"events-check-again","denotations":[{"id":"T14293","span":{"begin":22,"end":27},"obj":"Protein"},{"id":"T14294","span":{"begin":28,"end":38},"obj":"Gene_expression"}],"relations":[{"id":"R11843","pred":"themeOf","subj":"T14293","obj":"T14294"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T13751","span":{"begin":122,"end":126},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T13752","span":{"begin":205,"end":209},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    sentences

    {"project":"sentences","denotations":[{"id":"T11311","span":{"begin":0,"end":233},"obj":"Sentence"},{"id":"T187","span":{"begin":0,"end":233},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    2_test

    {"project":"2_test","denotations":[{"id":"16396836-11846982-76538218","span":{"begin":220,"end":222},"obj":"11846982"},{"id":"16396836-12218129-76538219","span":{"begin":223,"end":225},"obj":"12218129"},{"id":"16396836-10676951-76538220","span":{"begin":226,"end":228},"obj":"10676951"},{"id":"16396836-10720141-76538220","span":{"begin":226,"end":228},"obj":"10720141"},{"id":"16396836-11157493-76538220","span":{"begin":226,"end":228},"obj":"11157493"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    pmc-enju-pas

    {"project":"pmc-enju-pas","denotations":[{"id":"T12314","span":{"begin":0,"end":2},"obj":"IN"},{"id":"T12315","span":{"begin":3,"end":11},"obj":"NN"},{"id":"T12316","span":{"begin":11,"end":12},"obj":"-COMMA-"},{"id":"T12317","span":{"begin":13,"end":21},"obj":"JJ"},{"id":"T12318","span":{"begin":22,"end":27},"obj":"NN"},{"id":"T12319","span":{"begin":28,"end":38},"obj":"NN"},{"id":"T12320","span":{"begin":39,"end":42},"obj":"VB"},{"id":"T12321","span":{"begin":43,"end":48},"obj":"VB"},{"id":"T12322","span":{"begin":49,"end":51},"obj":"TO"},{"id":"T12323","span":{"begin":52,"end":54},"obj":"VB"},{"id":"T12324","span":{"begin":55,"end":56},"obj":"DT"},{"id":"T12325","span":{"begin":57,"end":63},"obj":"NN"},{"id":"T12326","span":{"begin":64,"end":67},"obj":"IN"},{"id":"T12327","span":{"begin":68,"end":75},"obj":"JJ"},{"id":"T12328","span":{"begin":76,"end":83},"obj":"NN"},{"id":"T12329","span":{"begin":84,"end":86},"obj":"IN"},{"id":"T12330","span":{"begin":87,"end":96},"obj":"NN"},{"id":"T12331","span":{"begin":96,"end":97},"obj":"-COMMA-"},{"id":"T12332","span":{"begin":98,"end":102},"obj":"JJ"},{"id":"T12333","span":{"begin":103,"end":105},"obj":"IN"},{"id":"T12334","span":{"begin":106,"end":113},"obj":"JJ"},{"id":"T12335","span":{"begin":114,"end":119},"obj":"JJ"},{"id":"T12336","span":{"begin":120,"end":126},"obj":"NN"},{"id":"T12337","span":{"begin":127,"end":136},"obj":"NN"},{"id":"T12338","span":{"begin":136,"end":137},"obj":"-COMMA-"},{"id":"T12339","span":{"begin":138,"end":145},"obj":"JJ"},{"id":"T12340","span":{"begin":146,"end":154},"obj":"NN"},{"id":"T12341","span":{"begin":155,"end":163},"obj":"NN"},{"id":"T12342","span":{"begin":163,"end":164},"obj":"-COMMA-"},{"id":"T12343","span":{"begin":165,"end":168},"obj":"CC"},{"id":"T12344","span":{"begin":169,"end":177},"obj":"JJ"},{"id":"T12345","span":{"begin":178,"end":182},"obj":"NN"},{"id":"T12346","span":{"begin":183,"end":191},"obj":"NN"},{"id":"T12347","span":{"begin":191,"end":192},"obj":"-COMMA-"},{"id":"T12348","span":{"begin":193,"end":196},"obj":"CC"},{"id":"T12349","span":{"begin":197,"end":202},"obj":"JJ"},{"id":"T12350","span":{"begin":203,"end":209},"obj":"NN"},{"id":"T12351","span":{"begin":210,"end":218},"obj":"NN"},{"id":"T12352","span":{"begin":219,"end":220},"obj":"-LRB-"},{"id":"T12353","span":{"begin":220,"end":231},"obj":"CD"},{"id":"T12354","span":{"begin":231,"end":232},"obj":"-RRB-"}],"relations":[{"id":"R10221","pred":"arg2Of","subj":"T12315","obj":"T12314"},{"id":"R10222","pred":"arg1Of","subj":"T12319","obj":"T12317"},{"id":"R10223","pred":"arg1Of","subj":"T12319","obj":"T12318"},{"id":"R10224","pred":"arg1Of","subj":"T12319","obj":"T12320"},{"id":"R10225","pred":"arg2Of","subj":"T12319","obj":"T12321"},{"id":"R10226","pred":"arg1Of","subj":"T12319","obj":"T12323"},{"id":"R10227","pred":"arg1Of","subj":"T12321","obj":"T12314"},{"id":"R10228","pred":"arg1Of","subj":"T12321","obj":"T12316"},{"id":"R10229","pred":"arg2Of","subj":"T12321","obj":"T12320"},{"id":"R10230","pred":"arg3Of","subj":"T12323","obj":"T12321"},{"id":"R10231","pred":"arg1Of","subj":"T12323","obj":"T12322"},{"id":"R10232","pred":"arg2Of","subj":"T12325","obj":"T12323"},{"id":"R10233","pred":"arg1Of","subj":"T12325","obj":"T12324"},{"id":"R10234","pred":"arg1Of","subj":"T12325","obj":"T12326"},{"id":"R10235","pred":"arg2Of","subj":"T12328","obj":"T12326"},{"id":"R10236","pred":"arg1Of","subj":"T12328","obj":"T12327"},{"id":"R10237","pred":"arg1Of","subj":"T12328","obj":"T12329"},{"id":"R10238","pred":"arg1Of","subj":"T12328","obj":"T12331"},{"id":"R10239","pred":"arg1Of","subj":"T12328","obj":"T12333"},{"id":"R10240","pred":"arg2Of","subj":"T12330","obj":"T12329"},{"id":"R10241","pred":"arg1Of","subj":"T12333","obj":"T12332"},{"id":"R10242","pred":"arg1Of","subj":"T12337","obj":"T12334"},{"id":"R10243","pred":"arg1Of","subj":"T12337","obj":"T12335"},{"id":"R10244","pred":"arg1Of","subj":"T12337","obj":"T12336"},{"id":"R10245","pred":"arg1Of","subj":"T12337","obj":"T12338"},{"id":"R10246","pred":"arg1Of","subj":"T12338","obj":"T12343"},{"id":"R10247","pred":"arg2Of","subj":"T12341","obj":"T12338"},{"id":"R10248","pred":"arg1Of","subj":"T12341","obj":"T12339"},{"id":"R10249","pred":"arg1Of","subj":"T12341","obj":"T12340"},{"id":"R10250","pred":"arg1Of","subj":"T12343","obj":"T12342"},{"id":"R10251","pred":"arg1Of","subj":"T12343","obj":"T12348"},{"id":"R10252","pred":"arg2Of","subj":"T12346","obj":"T12343"},{"id":"R10253","pred":"arg1Of","subj":"T12346","obj":"T12344"},{"id":"R10254","pred":"arg1Of","subj":"T12346","obj":"T12345"},{"id":"R10255","pred":"arg2Of","subj":"T12348","obj":"T12333"},{"id":"R10256","pred":"arg1Of","subj":"T12348","obj":"T12347"},{"id":"R10257","pred":"arg2Of","subj":"T12351","obj":"T12348"},{"id":"R10258","pred":"arg1Of","subj":"T12351","obj":"T12349"},{"id":"R10259","pred":"arg1Of","subj":"T12351","obj":"T12350"},{"id":"R10260","pred":"arg1Of","subj":"T12351","obj":"T12352"},{"id":"R10261","pred":"arg2Of","subj":"T12353","obj":"T12352"},{"id":"R10262","pred":"arg3Of","subj":"T12354","obj":"T12352"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    bionlp-st-ge-2016-spacy-parsed

    {"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T13547","span":{"begin":0,"end":2},"obj":"IN"},{"id":"T13548","span":{"begin":3,"end":11},"obj":"NN"},{"id":"T13549","span":{"begin":11,"end":12},"obj":","},{"id":"T13550","span":{"begin":13,"end":21},"obj":"JJ"},{"id":"T13551","span":{"begin":22,"end":27},"obj":"NN"},{"id":"T13552","span":{"begin":28,"end":38},"obj":"NN"},{"id":"T13553","span":{"begin":39,"end":42},"obj":"VBD"},{"id":"T13554","span":{"begin":43,"end":48},"obj":"VBN"},{"id":"T13555","span":{"begin":49,"end":51},"obj":"TO"},{"id":"T13556","span":{"begin":52,"end":54},"obj":"VB"},{"id":"T13557","span":{"begin":55,"end":56},"obj":"DT"},{"id":"T13558","span":{"begin":57,"end":63},"obj":"NN"},{"id":"T13559","span":{"begin":64,"end":67},"obj":"IN"},{"id":"T13560","span":{"begin":68,"end":75},"obj":"JJ"},{"id":"T13561","span":{"begin":76,"end":83},"obj":"NNS"},{"id":"T13562","span":{"begin":84,"end":86},"obj":"IN"},{"id":"T13563","span":{"begin":87,"end":96},"obj":"NNS"},{"id":"T13564","span":{"begin":96,"end":97},"obj":","},{"id":"T13565","span":{"begin":98,"end":102},"obj":"JJ"},{"id":"T13566","span":{"begin":103,"end":105},"obj":"IN"},{"id":"T13567","span":{"begin":106,"end":113},"obj":"NN"},{"id":"T13568","span":{"begin":114,"end":119},"obj":"JJ"},{"id":"T13569","span":{"begin":120,"end":126},"obj":"NNP"},{"id":"T13570","span":{"begin":127,"end":136},"obj":"NNS"},{"id":"T13571","span":{"begin":136,"end":137},"obj":","},{"id":"T13572","span":{"begin":138,"end":145},"obj":"JJ"},{"id":"T13573","span":{"begin":146,"end":154},"obj":"NN"},{"id":"T13574","span":{"begin":155,"end":163},"obj":"NN"},{"id":"T13575","span":{"begin":163,"end":164},"obj":","},{"id":"T13576","span":{"begin":165,"end":168},"obj":"CC"},{"id":"T13577","span":{"begin":169,"end":177},"obj":"JJ"},{"id":"T13578","span":{"begin":178,"end":182},"obj":"NN"},{"id":"T13579","span":{"begin":183,"end":191},"obj":"NN"},{"id":"T13580","span":{"begin":191,"end":192},"obj":","},{"id":"T13581","span":{"begin":193,"end":196},"obj":"CC"},{"id":"T13582","span":{"begin":197,"end":202},"obj":"NN"},{"id":"T13583","span":{"begin":203,"end":209},"obj":"NN"},{"id":"T13584","span":{"begin":210,"end":218},"obj":"NN"},{"id":"T13585","span":{"begin":219,"end":220},"obj":"-LRB-"},{"id":"T13586","span":{"begin":220,"end":228},"obj":"CD"},{"id":"T13587","span":{"begin":229,"end":231},"obj":"CD"},{"id":"T13588","span":{"begin":231,"end":232},"obj":"-RRB-"},{"id":"T13589","span":{"begin":232,"end":233},"obj":"."}],"relations":[{"id":"R11341","pred":"prep","subj":"T13547","obj":"T13554"},{"id":"R11342","pred":"pobj","subj":"T13548","obj":"T13547"},{"id":"R11343","pred":"punct","subj":"T13549","obj":"T13554"},{"id":"R11345","pred":"amod","subj":"T13550","obj":"T13552"},{"id":"R11348","pred":"compound","subj":"T13551","obj":"T13552"},{"id":"R11351","pred":"nsubjpass","subj":"T13552","obj":"T13554"},{"id":"R11353","pred":"auxpass","subj":"T13553","obj":"T13554"},{"id":"R11355","pred":"ROOT","subj":"T13554","obj":"T13554"},{"id":"R11356","pred":"aux","subj":"T13555","obj":"T13556"},{"id":"R11357","pred":"xcomp","subj":"T13556","obj":"T13554"},{"id":"R11358","pred":"det","subj":"T13557","obj":"T13558"},{"id":"R11360","pred":"attr","subj":"T13558","obj":"T13556"},{"id":"R11361","pred":"prep","subj":"T13559","obj":"T13558"},{"id":"R11363","pred":"amod","subj":"T13560","obj":"T13561"},{"id":"R11364","pred":"pobj","subj":"T13561","obj":"T13559"},{"id":"R11366","pred":"prep","subj":"T13562","obj":"T13561"},{"id":"R11367","pred":"pobj","subj":"T13563","obj":"T13562"},{"id":"R11368","pred":"punct","subj":"T13564","obj":"T13563"},{"id":"R11369","pred":"amod","subj":"T13565","obj":"T13566"},{"id":"R11370","pred":"prep","subj":"T13566","obj":"T13563"},{"id":"R11371","pred":"pobj","subj":"T13567","obj":"T13566"},{"id":"R11373","pred":"amod","subj":"T13568","obj":"T13570"},{"id":"R11374","pred":"compound","subj":"T13569","obj":"T13570"},{"id":"R11375","pred":"dobj","subj":"T13570","obj":"T13567"},{"id":"R11377","pred":"punct","subj":"T13571","obj":"T13570"},{"id":"R11378","pred":"amod","subj":"T13572","obj":"T13574"},{"id":"R11379","pred":"compound","subj":"T13573","obj":"T13574"},{"id":"R11381","pred":"conj","subj":"T13574","obj":"T13570"},{"id":"R11382","pred":"punct","subj":"T13575","obj":"T13574"},{"id":"R11383","pred":"cc","subj":"T13576","obj":"T13574"},{"id":"R11384","pred":"amod","subj":"T13577","obj":"T13578"},{"id":"R11386","pred":"conj","subj":"T13578","obj":"T13574"},{"id":"R11387","pred":"conj","subj":"T13579","obj":"T13574"},{"id":"R11388","pred":"punct","subj":"T13580","obj":"T13579"},{"id":"R11390","pred":"cc","subj":"T13581","obj":"T13579"},{"id":"R11391","pred":"compound","subj":"T13582","obj":"T13584"},{"id":"R11393","pred":"compound","subj":"T13583","obj":"T13584"},{"id":"R11394","pred":"conj","subj":"T13584","obj":"T13579"},{"id":"R11395","pred":"punct","subj":"T13585","obj":"T13586"},{"id":"R11396","pred":"appos","subj":"T13586","obj":"T13584"},{"id":"R11400","pred":"appos","subj":"T13587","obj":"T13584"},{"id":"R11402","pred":"punct","subj":"T13588","obj":"T13584"},{"id":"R11403","pred":"punct","subj":"T13589","obj":"T13554"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    bionlp-st-ge-2016-reference-tees

    {"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T14423","span":{"begin":22,"end":27},"obj":"Protein"},{"id":"T14424","span":{"begin":28,"end":38},"obj":"Gene_expression"}],"relations":[{"id":"R11919","pred":"themeOf","subj":"T14423","obj":"T14424"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    bionlp-st-ge-2016-reference

    {"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T11259","span":{"begin":22,"end":27},"obj":"Protein"},{"id":"T11260","span":{"begin":28,"end":38},"obj":"Gene_expression"}],"relations":[{"id":"R9215","pred":"themeOf","subj":"T11259","obj":"T11260"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T12521","span":{"begin":22,"end":27},"obj":"Q15306"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}

    test2

    {"project":"test2","denotations":[{"id":"T11119","span":{"begin":22,"end":27},"obj":"Protein"},{"id":"T11120","span":{"begin":28,"end":38},"obj":"Gene_expression"}],"relations":[{"id":"R9130","pred":"themeOf","subj":"T11119","obj":"T11120"}],"text":"In addition, abundant IRF-4 expression was found to be a marker for various subsets of lymphomas, such as diffuse large B-cell lymphomas, primary effusion lymphoma, and marginal zone lymphoma, and adult T-cell leukemia (11,31,50–52)."}